Suven Pharmaceuticals Ltd Half Yearly Results

Gross Sales

1,104.88

1,516.65

1,091.85

472.75

578.6

Excise Duty

0

0

0

0

0

Net Sales

1,104.88

1,516.65

1,091.85

472.75

578.6

Other Operating Income

0

0

0

0

0

Other Income

29.77

33.61

35.6

31.4

30.51

Total Income

1,134.65

1,550.26

1,127.45

504.15

609.11

Total Expenditure

880.02

1,065.84

761.38

331.86

313.68

PBIDT

254.63

484.42

366.07

172.29

295.43

Interest

18.94

21.25

19.81

5.8

1.65

PBDT

235.69

463.17

346.26

166.49

293.78

Depreciation

89.16

97.73

69.07

30.17

24.43

Minority Interest Before NP

0

0

0

0

0

Tax

45.22

101.61

70.67

33.2

65.6

Deferred Tax

-11.48

-6.8

-7.09

3

3.59

Reported Profit After Tax

112.79

270.63

213.61

100.13

200.15

Minority Interest After NP

-10.17

-2.87

-0.23

0

0

Net Profit after Minority Interest

122.96

273.5

213.84

100.13

200.15

Extra-ordinary Items

-5.6

-15.78

0

0

0

Adjusted Profit After Extra-ordinary item

128.56

289.28

213.84

100.13

200.15

EPS (Unit Curr.)

3.22

10.74

5.61

3.93

7.86

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

38.26

25.46

25.46

25.46

25.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

23.04

31.94

33.52

36.44

51.05

PBDTM(%)

-

-

-

-

-

PATM(%)

10.2

17.84

19.56

21.18

34.59